Beth Israel Deaconess Medical Center/MGH/DFCI — Boston, Massachusetts

Beth Israel Deaconess Medical Center/MGH/DFCI is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Beth Israel Deaconess Medical Center/MGH/DFCI has participated in 1 clinical trials.

Therapeutic areas: Prostate Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Deaconess Medical Center/MGH/DFCI?

Beth Israel Deaconess Medical Center/MGH/DFCI has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Deaconess Medical Center/MGH/DFCI conducted?

Beth Israel Deaconess Medical Center/MGH/DFCI has 1 clinical trials on record. Their work covers Prostate Cancer.

Is Beth Israel Deaconess Medical Center/MGH/DFCI accredited by Crixeo Health?

Beth Israel Deaconess Medical Center/MGH/DFCI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Israel Deaconess Medical Center/MGH/DFCI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.